- Home
- ALEC vs ULBI Comparison
ALEC vs ULBI Comparison
Compare ALEC & ULBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- ULBI
- Stock Information
- Founded
- ALEC 2013
- ULBI 1990
- Country
- ALEC United States
- ULBI United States
- Employees
- ALEC N/A
- ULBI N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- ULBI Industrial Machinery/Components
- Sector
- ALEC Health Care
- ULBI Miscellaneous
- Exchange
- ALEC Nasdaq
- ULBI Nasdaq
- Market Cap
- ALEC 124.0M
- ULBI 112.3M
- IPO Year
- ALEC 2019
- ULBI 1992
- Fundamental
- Price
- ALEC $1.27
- ULBI $5.15
- Analyst Decision
- ALEC Hold
- ULBI Strong Buy
- Analyst Count
- ALEC 9
- ULBI 1
- Target Price
- ALEC $3.40
- ULBI $14.00
- AVG Volume (30 Days)
- ALEC 3.0M
- ULBI 47.1K
- Earning Date
- ALEC 11-06-2025
- ULBI 11-18-2025
- Dividend Yield
- ALEC N/A
- ULBI N/A
- EPS Growth
- ALEC N/A
- ULBI N/A
- EPS
- ALEC N/A
- ULBI 0.10
- Revenue
- ALEC $69,048,000.00
- ULBI $186,530,000.00
- Revenue This Year
- ALEC N/A
- ULBI $31.30
- Revenue Next Year
- ALEC $314.69
- ULBI $6.24
- P/E Ratio
- ALEC N/A
- ULBI $50.31
- Revenue Growth
- ALEC 12.26
- ULBI 12.94
- 52 Week Low
- ALEC $0.87
- ULBI $4.07
- 52 Week High
- ALEC $4.18
- ULBI $9.52
- Technical
- Relative Strength Index (RSI)
- ALEC 33.72
- ULBI 23.55
- Support Level
- ALEC $1.16
- ULBI $5.65
- Resistance Level
- ALEC $1.60
- ULBI $7.13
- Average True Range (ATR)
- ALEC 0.13
- ULBI 0.34
- MACD
- ALEC 0.03
- ULBI -0.17
- Stochastic Oscillator
- ALEC 22.73
- ULBI 4.84
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About ULBI Ultralife Corporation
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.